Approved by the FDA, 3D-printed drug set to change future of medication

The 3D-printed Spritam levetiracetam (Credit: Aprecia Pharmaceuticals)
The 3D-printed Spritam levetiracetam (Credit: Aprecia Pharmaceuticals)

The term “designer drug” may soon refer less to the illicit kind and more to custom creations by the pharmaceutical industry. Aprecia Pharmaceuticals Company has just had its proprietary ZipDose Technology platform approved by the US Food and Drug Administration (FDA). This marks the very first instance that the FDA has given the green light for a 3D-printed drug product.

The use of 3D printing in the medical field is somewhat new, but growing rapidly. Bio-printing has proven to be an efficient way to create living tissues, and 3D-printed implants are able to deliver drugs more effectively. Now, with the FDA’s approval, Aprecia can continue the creation of its 3D-printed drug, possibly paving the way for future drugs.

Spritam levetiracetam is an oral prescription for the treatment of seizures and those affected by epilepsy. Aprecia’s ZipDose Technology enables the delivery of this drug, up to 1,000 mg per dose, with just a sip of water. This rapid disintegration method is achieved by 3D printing Spritam with a porous formulation. As a result, each dose is easy to take and does not require any measuring.

Read more: Approved by the FDA, 3D-printed drug set to change future of medication

 

The Latest on: 3D-printed drug

[google_news title=”” keyword=”3D-printed drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News

 

See Also

The Latest on: 3D-printed drug

via  Bing News

 

What's Your Reaction?
Don't Like it!
0
I Like it!
0
Scroll To Top